Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines

In Vivo

Volumn 17, Issue 2, 2003, Pages 145-149

  Molnar, Joseph ^a   Molnar, Annamaria ^a   Mucsi, Ilona ^a   Pinter, Oliver ^a   Nagy, Beatrix ^a   Varga, Andreas ^b   Motohashi, Noboru ^c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b HUMBOLDT UNIVERSITY   (Germany)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Phenothiazines; Reversal of multidrug resistance; Tomato lectin; Vinblastin

Indexed keywords

10 (3 PHTHALIMIDOPROPYL) 2 CHLORO 10H PHENOTHIAZINE; 10 (4 PHTHALIMIDOBUTYL) 2 CHLORO 10H PHENOTHIAZINE; 5 OXO 5H BENZO[A]PHENOTHIAZINE; 6 METHYL 5 OXO 5H BENZO[A]PHENOTHIAZINE; 6,9 DIHYDROXYCHLORPROMAZINE; ABC TRANSPORTER; AMINE; AROMATIC AMINO ACID; CALCIUM CHANNEL; CHLORPROMAZINE; CISPLATIN; COLCHICINE; CONCANAVALIN A; DEXTRO METHOPROMAZINE; FLUOROURACIL; GLYCOPROTEIN P; LACTOSE; LEVOME THOPROMAZINE; MANNOSE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; N ACETYLGLUCOSAMINE; PHENOTHIAZINE DERIVATIVE; PLANT LECTIN; PROMETHAZINE; RHODAMINE 123; TOMATO LECTIN; TYROSINE; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE; WHEAT GERM AGGLUTININ;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CELL MEMBRANE; CONTROLLED STUDY; DIPOLE; DRUG ACTIVITY; DRUG BINDING SITE; DRUG CONCENTRATION; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; GENETIC TRANSFECTION; LYMPHOMA CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STEREOSPECIFICITY; T CELL LYMPHOMA;

EID: 0038546587     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 58: 137-171, 1989.
2. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62: 385-427, 1993.
3. Andreana A, Gollapudi S and Gupta S: Salmonella typhimurium induces expression of P glycoprotein (multidrug resistance 1 gene product) in a promonocytic cell line chronically infected with human immunodeficiency virus type 1. J Infect Dis 169: 760-765, 1994.
4. Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li X and Nishino T: Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug- resistant strains of Pseudomonas aeruginosa. Mol Microbiol 21: 713-724, 1996.
5. Matthysse AG, Yarnall HA and Young N: Requirement for genes with homology to ABC transport systems for attachment and virulence of Agrobacterium tumefaciens. J Bacteriol 178: 5305-5308, 1996.
6. Gerlach JH, Endicott JA, Juranka PF, Henderson G, Sarangi F, Deuchars KL and Ling V: Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324: 485-489, 1986.
7. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M and Bille J: Mechanisms of resistance to azole antifungal agents in Candida albicans isolated from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 2378-2386, 1995.
8. Broeks A, Gerrard B, Allikmets R, Dean M and Plasterk RHA: Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J 15: 6132-6143, 1996.
9. Hegewisch-Becker S, Fliegener M, Tsuruo T, Zeller W and Hossfeld DK: Multidrug resistance (mdr 1) in adult acute leukemia at diagnosis: Correlation with response to induction chemotherapy. Onkologie 16: 264-269, 1993.
10. Ichikawa M, Yoshimura A, Furukawa T, Sumizawa T, Nakazima Y, and Akiyama S: Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues. Biochim Biophy Acta 1073: 309-315, 1991
11. Hasegawa S, Abe T, Naito S, Kotoh S, Kumazawa J, Hipfner DR, Deeley RG; Cole SPC and Kuwano M: Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Brit J Cancer 71: 907-913, 1995.
12. Zaman GJR, Flens MJ, Van Leusden MR, De Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826, 1994.
13. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, Van Heijningen, THM, Van Kalken CK, Slovak ML, De Vries EGE, Van Der Valk P, Meijer CJLM and Pinedo HM: Overexpression of a Mdr 1 10,000 versicular protein in non-P-glycoprotein- mediated multidrug resistance. Cancer Res 53: 1475-1479, 1993.
14. Whelan RDH, Hosking LK, Townsend AJ, Cowan KH and Hill BT: Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines. Cancer Commun 1: 359-365, 1989.
15. Kellner U, Hutchinson L, Seidel A, Lage H, Danks MK, Dietel M and Kaufmann SH: Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. Int J Cancer 71: 817-824, 1997.
16. Molnár J, Hevér A, Fakla I, Fischer J, Ocsovszki I and Aszalós A.: Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug-resistant tumor cells. Anticancer Res 17: 481-486, 1997.
17. Molnár J, Mándi Y, Boda K and Földeák S: The effect of ring-substituted and quarternary chlorpromazine derivatives on the survival of the NK/Ly ascites tumor bearing mice. Neoplasma 29: 215-222, 1982.
18. Motohashi N: Test for antitumor activities of phenothiazines and phenoxazines. (in Japanese). Yakugaku Zasshi 103: 364-371, 1983.
19. Motohashi N, Kawase N, Kurihara T, Hevér A, Nagy S, Tanaka M and Molnár J: Synthesis and antitumor activities of 1-(2-chloroethyl)-3-(2-substituted-10h, ∼ phenothiazin-10-yl) alkylureas as potent anticancer agents. Anticancer Res 16: 2525-2532, 1996.
20. Cornwell MM, Pastan I and Gottesman MM: Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166-2170, 1987.
21. Molnár J, Szabó D, Mándi Y, Mucsi I, Fischer J, Varga A, König S and Motohashi N: Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds. Anticancer Res 18: 3033-3038, 1998.
22. Szabó D and Molnár J: The role of stereoselectivity of chemosensitizers in the reversal of multidrug-resistance of mouse lymphoma. Anticancer Res 18: 3039-3044, 1998.
23. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I and Willingham MC: Cellular localization of the multidrug- resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738, 1987.
24. Keller RP, Altermatt HJ, Donatsch P, Zihlmann H, Laissue JA, Hiestand PC: Pharmacologic interactions between the resistance-modifying cyclosporine SDZ PSC 833 and etoposide (VP 16-213) enhance in vivo cytostatic activity and toxicity. Int J Cancer 51: 433-438, 1992.
25. Molnár J, Haszon I, Bodrogi T, Martonyi E and Turi S: Synergistic effect of promethazine with gentamycine in frequently reccurring pyelonephritis. Int J Urol Nephrol 22, 5: 405-411, 1990.